Table 2.
The Characteristics of Cytokines in Patients
| Continuous Variable | Median | Range | Variable | Median | Range |
|---|---|---|---|---|---|
| EGF | 51.12 | 355–231.54 | IL17A | 3.44 | 0.90–3365.00 |
| FGF2 | 79.70 | 17.28–189.91 | IL1RA | 31.13 | 0.90–5847.00 |
| Eotaxin | 90.08 | 18.46–241.16 | IL-1α | 6.64 | 4.04–315.71 |
| TGF-α | 2.53 | 2.53–8.30 | IL-9 | 1.25 | 1.25–4.23 |
| GCSF | 28.26 | 2.42–2874.00 | IL-1b | 2.83 | 2.83–13.35 |
| Flt3L | 2.23 | 2.23–74.09 | IL-2 | 1.53 | 0.75–19.97 |
| GMCSF | 7.14 | 1.96–51.83 | IL-3 | 1.54 | 1.54–7.11 |
| Fractalkine | 47.14 | 4.23–288.28 | IL-4 | 36.24 | 3.76–430.10 |
| IFN-α2 | 26.17 | 1.46–89.67 | IL-5 | 2.76 | 2.76–5.02 |
| IFN-γ | 6.18 | 1.88–88.55 | IL-6 | 13.34 | 3.05–2835.00 |
| GRO | 1384.0 | 7.37–8310.00 | IL-7 | 2.71 | 2.67–13.36 |
| IL-10 | 6.86 | 2.52–850.02 | IL-8 | 23.36 | 2.61–2020.00 |
| MCP3 | 3.62 | 3.62–33.06 | IP-10 | 550.90 | 163.69–2072.00 |
| IL-12P40 | 3.94 | 3.94–54.17 | MCP-1 | 343.64 | 127.87–6253.00 |
| MDC | 614.47 | 50.23–1001.00 | MIP-1α | 6.59 | 3.04–167.26 |
| IL-12P70 | 3.48 | 3.00–207.01 | MIP-1β | 54.50 | 13.61–1925.00 |
| IL-13 | 2.57 | 2.57–7.36 | TNF-α | 18.79 | 6.40–417.89 |
| IL-15 | 1.93 | 1.03–8.11 | TNF-β | 1.00 | 1.00–8.23 |
| sCD40L | 1597 | 230.34–8481.00 | VEGF | 47.82 | 3.72–298.02 |
Abbreviations: EGF, epidermal growth factor; FGF2, fibroblast growth factor-2; TGF-α, tumor growth factor-2; GCSF, granulocyte colony-stimulating factor; Flt3L, FMS like tyrosine kinase 3 ligand; GMCSF, granulocyte-macrophage colony-stimulating factor; IFN, interferon; GRO, growth regulates oncogene; IL, interleukin.